SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001104659-24-041812
Filing Date
2024-04-01
Accepted
2024-04-01 16:02:28
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-01

Document Format Files

Seq Description Document Type Size
1 FORM NT 10-K tm2410325d1_nt10k.htm NT 10-K 31433
  Complete submission text file 0001104659-24-041812.txt   32853
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-31326 | Film No.: 24809038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)